TB-500 (5mg Vial) Laboratory Protocol & Reconstitution Guide
Navigation Guide
Summary of Research Highlights
TB-500 is a synthetic version of the naturally occurring peptide Thymosin Beta-4 (Tβ4). It is a major actin-sequestering protein found in almost all human cells. In research models, TB-500 is utilized to study the acceleration of tissue repair, including muscle, tendon, ligament, and skin, through its unique ability to promote cell migration and angiogenesis.
Titration Schedule & Experimental Dosing
Preclinical models for TB-500 often differentiate between a "Loading Phase" and a "Maintenance Phase." By utilizing a daily titration schedule, researchers can identify the Minimum Effective Dose (MED) while minimizing potential systemic fatigue. This structured approach ensures that the actin-binding receptors are saturated gradually.
| Research Duration | Daily Research Dose | Weekly Equivalent | Draw Volume (2.5mg/mL) |
|---|---|---|---|
| Weeks 1 – 2 (Start) | 250 mcg | 1.75 mg | 10 Units (0.10 mL) |
| Weeks 3 – 8 (Standard) | 500 mcg | 3.5 mg | 20 Units (0.20 mL) |
| Weeks 9 – 12 (Intensive) | 1,000 mcg (1mg) | 7.0 mg | 40 Units (0.40 mL) |
Required Lab Equipment
For a standard 12-week research protocol involving daily administration of TB-500, a strictly sterile "cold chain" environment must be maintained. The following inventory is required:
Peptide Inventory
- TB-500 Vials: 9 x 5mg Vials (Total 45mg).
- Estimated for 500mcg/day average protocol.
Solvents & Syringes
- Bacteriostatic Water: 2 x 10mL bottles (BWFI).
- Insulin Syringes: 100 x U-100 (0.5ml preferred).
Sanitization
- Prep Pads: 200 x 70% Isopropyl swabs.
- Disposal: 1 x Biohazard sharps unit.
Step-by-Step Mixing Guide
The secondary structure of TB-500 is highly sensitive to mechanical force. Rough handling or high-pressure injection of water can lead to "peptide shearing," which significantly degrades the biological activity of the 43-amino acid chain.
- Sterilization: Wipe the rubber stoppers of both the TB-500 vial and the Bacteriostatic Water vial with a fresh alcohol swab. Allow to air dry for 30 seconds.
- Pressure Equalization: Draw 2.0 mL of air into your syringe and inject it into the Bac Water vial to prevent a vacuum from forming.
- Draw Diluent: Slowly draw 2.0 mL of Bacteriostatic Water into the syringe.
- The "Wall" Drip: Insert the needle into the TB-500 vial at a 45-degree angle. Drip the water slowly down the glass wall.
- Dissolution: Gently roll the vial between your palms. Never shake. The solution should turn perfectly clear within 60 seconds.
- Equilibration: Allow the reconstituted solution to rest in the refrigerator (2–8°C) for 15 minutes.
Technical Appendix: Cellular Synergy
The following analysis provides the technical depth required for institutional research and advanced laboratory study of the TB-500 molecule.
I. The Actin-Binding Pathway
The primary function of TB-500 is its interaction with G-Actin (globular actin). Actin is a fundamental protein involved in the structure and movement of cells. By sequestering G-actin, TB-500 prevents its polymerization into F-actin, maintaining a pool of building blocks that the cell uses to move to the site of an injury.
II. Stability and Lifecycle Analysis
- Lyophilized State: Stable at room temperature for up to 60 days. Store at -20°C for long-term integrity.
- Reconstituted State: Must be kept at 2–8°C. Potency remains peak for 14–21 days.
III. Research FAQ
Q: Why is the molecular mass higher than other repair peptides?
A: The 43-amino acid structure of Tβ4 is larger than many signaling fragments, requiring a higher milligram mass for receptor saturation.
IV. Clinical References
- Philp D, et al. (2003). "Thymosin beta4 promotes angiogenesis and wound healing."
- Sosne G, et al. (2010). "Thymosin beta 4: A novel corneal wound healing agent."
- Laboratory Reference Standards (2026). "Actin-binding protein stability analysis."